Name Development Level Target Family
Name Description
trastuzumab A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.
TCRDv4.6.9
DrugCentral Indication
DrugCentral
trastuzumab